Dr. Leopold has more than 30 years of research and management experience in the field of cancer research and drug development. Dr. Leopold has extensive professional experience in cancer drug discovery and evaluation, target validation, clinical development of anticancer agents, contract research, toxicology, and engineering. His personal research interests have focused on various technologies for in vivo evaluation of anticancer potential and the in vivo assessment of drug function at the molecular level. Prior to joining MIR, Dr. Leopold was Executive Director of Cancer Pharmacology and Therapeutic Area Site Leader for Oncology at Pfizer's Ann Arbor Laboratories. He was a co-founder of the Cancer Drug Discovery Program at Parke-Davis in 1982, assuming leadership of the program in 1989. During his tenure at Parke-Davis/Pfizer, more than 18 novel agents spanning at least 10 mechanistic classes were discovered and developed to clinical trial. Upon completion of his Ph.D., Dr. Leopold joined the Chemotherapy Division of Southern Research Institute as a Research Oncologist where he also worked in the Toxicology Division as a Research Toxicologist. Dr. Leopold received his Ph.D. in Oncology from the McArdle Institute for Cancer Research at the University of Wisconsin. He also holds a M.S. in Biochemistry and a B.S. in Chemical Engineering, both from the University of Illinois.

Dr. Elliott has more than 22 years of experience in the field of cancer research, cancer drug evaluation, and drug development. Dr. Elliott has extensive experience in the field of in vivo drug evaluation and cancer cell biochemistry. Prior to joining MIR, Dr. Elliott was an Associate Research Fellow, leading the in vivo Cancer Pharmacology effort at Pfizer's Ann Arbor Laboratories. Dr. Elliott joined Parke-Davis in 1987, assuming the group leader position in 1991. During his career at Parke-Davis/Pfizer, more than 13 compounds from a number of mechanistic classes were discovered and advanced to clinical trial, based in part upon the pre-clinical studies from Dr. Elliott's Laboratory. Dr. Elliott received post-doctoral training in Biochemistry at the Laboratory for Experimental Oncology at the Indiana University School of Medicine and University of Massachusetts Medical School. Dr. Elliott received his Ph.D. in Cancer Research from the Department of Medicinal Chemistry and Pharmacology, Purdue University School of Pharmacy.

Dr. Ross is a Professor of Radiology and Associate Professor of Biological Chemistry at the University of Michigan where he serves as Co-Director of the Center for Molecular Imaging. He received his Ph.D. in Biophysics from the University of California at Davis along with B.S. and M.S. degrees in Chemistry. He completed an American Brain Tumor Postdoctoral Fellowship in Magnetic Resonance Studies of malignant brain tumors at the University of Minnesota, Center for Magnetic Resonance Research.

Ms. Engel has a B.B.A. in Management from Eastern Michigan University. She has 8 years of business administration experience in the pharmaceutical industry and joined MIR after working at Pfizer, Michigan Labs. Lisa is responsible for both Operations and HR Management at MIR.

Mr. Urban has 7 years of experience in Molecular Biology and Biochemistry. Mr. Urban received his B.A. in Biology, General Science and Physical Science from Concordia College. He also has a M.S. in Molecular Biology, and is working on a M.B.A. degree as well as degrees in Web Design and Criminal Justice. Frank is responsible for MIR's marketing operations, business development, contract maintenance, licensing and customer relations.

Mr. Miller has a broad financial background with significant experience in business operations and development, financial accounting, financial analysis and administration over 20 years. Greg has spent most of his career in private industry such as telecommunications He received his B.B.A. from Western Michigan University.

Ms. Hammar has a BA in Marketing from Michigan State University and a MSA in Accounting from Eastern Michigan University. She has over 25 years of experience in commercial lending, accounting and business operations. Ms. Hammar's primary duties include accounts payable, accounts receivable, general ledger account reconciliation and administrative duties.

Dr. Vinod Kaimal holds Bachelors and Masters degrees in electrical engineering and a doctorate in Biomedical engineering with a focus on medical imaging. Prior to joining MIR, Dr. Kaimal worked at the Cincinnati Children's Hospital on his doctoral dissertation on magnetic resonance microscopy of tumor-targeted liposomes. At MIR, Dr. Kaimal is responsible for the design, planning and execution of imaging studies across all imaging modalities and associated data analysis and reporting. He is also responsible for the development and validation of new and existing imaging technologies.

 

Mr. Lister holds a B.S. degree in Biology from Eastern Michigan University and is a certified Laboratory Animal Technician. Richard has 4 years of animal husbandry experience, more than 10 years of experience in pharmacokinetics and drug metabolism at Parke-Davis/Pfizer and has worked across multiple disease areas. He has almost 3 years of experience in the in vivo evaluation of anticancer agents at MIR. Richard is ALAS certified and a highly skilled small animal surgeon.

Mr. Howard has more than 25 years of experience in the field of cancer research, drug evaluation, and drug development. Mr. Howard was a Senior Scientist in the in vivo Cancer Pharmacology Department at Pfizer's Ann Arbor Laboratories and has worked exclusively in the area of in vivo evaluation of anticancer drug candidates. Mr. Howard received his Associate degree in Biology from Lawson State College. Curtis performs in vivo pharmacology experiments for anticancer drug evaluation at MIR.

Ms. Meade has 18 years of experience in the pharmaceutical industry, working at Parke-Davis/Pfizer, in pathology and experimental toxicology, cancer pharmacology and dermatology pharmacology. Additionally she has over nine years of experience as a veterinary technician. Mary Anne has attended Wayne State University, and is a certified AALAS technologist. Ms. Meade performs in vivo pharmacology experiments for anti-cancer and anti-inflammatory drug evaluation at MIR.